Your browser doesn't support javascript.
loading
Low-dose rituximab as an adjuvant therapy in pemphigus.
Gupta, Jaya; Raval, Ranjan C; Shah, Arti N; Solanki, Rekha B; Patel, Dhara D; Shah, Kaksha B; Badheka, Ami D; Shah, Keyur B; Aggarwal, Neetish K; Ravishankar, Vaaruni.
Afiliación
  • Gupta J; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Raval RC; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Shah AN; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Solanki RB; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Patel DD; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Shah KB; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Badheka AD; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Shah KB; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Aggarwal NK; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
  • Ravishankar V; Department of Dermatology, NHL Medical College, VS Hospital, Ahmedabad, Gujarat, India.
Indian J Dermatol Venereol Leprol ; 83(3): 317-325, 2017.
Article en En | MEDLINE | ID: mdl-28366912
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pénfigo / Rituximab / Antineoplásicos Inmunológicos Idioma: En Revista: Indian J Dermatol Venereol Leprol Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Pénfigo / Rituximab / Antineoplásicos Inmunológicos Idioma: En Revista: Indian J Dermatol Venereol Leprol Año: 2017 Tipo del documento: Article